← Medical directoryCondition
Worsening heart failure
Episodes of heart failure decompensation. In the SUMMIT trial, tirzepatide reduced these episodes compared with placebo (HR 0.54), and this was the main driver of the benefit seen in the composite endpoint.
Institutional endorsement by Clínica Evolution
This entry is for information. Your case requires an individual medical assessment.





